top of page
AEnB2Uq_HIiXrr6Uye1O7aZ5edPEz3r8ICmVEm8k9WIpa8GnDYiuQwMuSahKqwy82Yi7yRhU9ZSJdY5rzHIdRqOnNl
AAA+Logo.png

ABOUT ADVANCED ACCELERATOR APPLICATIONS

Advanced Accelerator Applications USA, Inc. (AAA), a Novartis company, is developing targeted radioligand therapies and precision imaging radioligands for oncology indications. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA has a legacy as a leader in radiopharmaceutical drugs for Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT) diagnostic imaging. 

For more information, please visit: www.adacap.com.
164649_AAA+Nuclear+Medicine+Infographic_Digital+v4 - 2_001.png
164649_AAA+Nuclear+Medicine+Infographic_Digital+v4 - 2_002.png

Contact a representative:

Laran L. Hyder, MHA

Associate Director, US Patient Advocacy, NET & RST

laran.hyder@novartis.com

(617)-413-4296

bottom of page